{"pmid":32344568,"title":"RT-qPCR Testing of SARS-CoV-2: A Primer.","text":["RT-qPCR Testing of SARS-CoV-2: A Primer.","Testing for the presence of coronavirus is an essential diagnostic tool for monitoring and managing the current COVID-19 pandemic. The only reliable test in current use for testing acute infection targets the genome of SARS-CoV-2, and the most widely used method is quantitative fluorescence-based reverse transcription polymerase chain reaction (RT-qPCR). Despite its ubiquity, there is a significant amount of uncertainty about how this test works, potential throughput and reliability. This has resulted in widespread misrepresentation of the problems faced using this test during the current COVID-19 epidemic. This primer provides simple, straightforward and impartial information about RT-qPCR.","Int J Mol Sci","Bustin, Stephen A","Nolan, Tania","32344568"],"abstract":["Testing for the presence of coronavirus is an essential diagnostic tool for monitoring and managing the current COVID-19 pandemic. The only reliable test in current use for testing acute infection targets the genome of SARS-CoV-2, and the most widely used method is quantitative fluorescence-based reverse transcription polymerase chain reaction (RT-qPCR). Despite its ubiquity, there is a significant amount of uncertainty about how this test works, potential throughput and reliability. This has resulted in widespread misrepresentation of the problems faced using this test during the current COVID-19 epidemic. This primer provides simple, straightforward and impartial information about RT-qPCR."],"journal":"Int J Mol Sci","authors":["Bustin, Stephen A","Nolan, Tania"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32344568","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.3390/ijms21083004","keywords":["covid-19","sars","pandemic","real-time fluorescence pcr","reverse transcription"],"topics":["Diagnosis"],"weight":1,"_version_":1665441658291879937,"score":8.599203,"similar":[{"pmid":32333644,"title":"RT-LAMP for rapid diagnosis of coronavirus SARS-CoV-2.","text":["RT-LAMP for rapid diagnosis of coronavirus SARS-CoV-2.","The pandemic coronavirus SARS-CoV-2 in the world has caused a large infected population suffering from COVID-19. To curb the spreading of the virus, WHO urgently demanded an extension of screening and testing; thus, a rapid and simple diagnostic method is needed. We applied a reverse transcription-loop-mediated isothermal amplification (RT-LAMP) to achieve the detection of SARS-CoV-2 in 30 min. We designed four sets of LAMP primers (6 primers in each set), targeting the viral RNA of SARS-CoV-2 in the regions of orf1ab, S gene and N gene. A colorimetric change was used to report the results, which enables the outcome of viral RNA amplification to be read by the naked eye without the need of expensive or dedicated instrument. The sensitivity can be 80 copies of viral RNA per ml in a sample. We validated the RT-LAMP method in a hospital in China, employing 16 clinic samples with 8 positives and 8 negatives. The testing results are consistent with the conventional RT-qPCR. In addition, we also show that one-step process without RNA extraction is feasible to achieve RNA amplification directly from a sample. This rapid, simple and sensitive RT-LAMP method paves a way for a large screening at public domain and hospitals, particularly regional hospitals and medical centres in rural areas.","Microb Biotechnol","Huang, Wei E","Lim, Boon","Hsu, Chia-Chen","Xiong, Dan","Wu, Wei","Yu, Yejiong","Jia, Huidong","Wang, Yun","Zeng, Yida","Ji, Mengmeng","Chang, Hong","Zhang, Xiuming","Wang, Hui","Cui, Zhanfeng","32333644"],"abstract":["The pandemic coronavirus SARS-CoV-2 in the world has caused a large infected population suffering from COVID-19. To curb the spreading of the virus, WHO urgently demanded an extension of screening and testing; thus, a rapid and simple diagnostic method is needed. We applied a reverse transcription-loop-mediated isothermal amplification (RT-LAMP) to achieve the detection of SARS-CoV-2 in 30 min. We designed four sets of LAMP primers (6 primers in each set), targeting the viral RNA of SARS-CoV-2 in the regions of orf1ab, S gene and N gene. A colorimetric change was used to report the results, which enables the outcome of viral RNA amplification to be read by the naked eye without the need of expensive or dedicated instrument. The sensitivity can be 80 copies of viral RNA per ml in a sample. We validated the RT-LAMP method in a hospital in China, employing 16 clinic samples with 8 positives and 8 negatives. The testing results are consistent with the conventional RT-qPCR. In addition, we also show that one-step process without RNA extraction is feasible to achieve RNA amplification directly from a sample. This rapid, simple and sensitive RT-LAMP method paves a way for a large screening at public domain and hospitals, particularly regional hospitals and medical centres in rural areas."],"journal":"Microb Biotechnol","authors":["Huang, Wei E","Lim, Boon","Hsu, Chia-Chen","Xiong, Dan","Wu, Wei","Yu, Yejiong","Jia, Huidong","Wang, Yun","Zeng, Yida","Ji, Mengmeng","Chang, Hong","Zhang, Xiuming","Wang, Hui","Cui, Zhanfeng"],"date":"2020-04-26T11:00:00Z","year":2020,"_id":"32333644","week":"202017|Apr 20 - Apr 26","doi":"10.1111/1751-7915.13586","source":"PubMed","topics":["Diagnosis"],"weight":1,"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1665071049703686144,"score":189.24193},{"pmid":32276051,"pmcid":"PMC7144851","title":"Development of Reverse Transcription Loop-mediated Isothermal Amplification (RT-LAMP) Assays Targeting SARS-CoV-2.","text":["Development of Reverse Transcription Loop-mediated Isothermal Amplification (RT-LAMP) Assays Targeting SARS-CoV-2.","Epidemics of Coronavirus Disease 2019 (COVID-19) now have more than 100,000 confirmed cases worldwide. Diagnosis of COVID-19 is currently performed by RT-qPCR methods, but the capacity of RT-qPCR methods is limited by its requirement of high-level facilities and instruments. Here, we developed and evaluated RT-LAMP assays to detect genomic RNA of SARS-CoV-2, the causative virus of COVID-19. RT-LAMP assays in this study can detect as low as 100 copies of SARS-CoV-2 RNA. Cross-reactivity of RT-LAMP assays to other human Coronaviruses was not observed. We also adapted a colorimetric detection method for our RT-LAMP assay so that the tests potentially performed in higher throughput.","J Mol Diagn","Park, Gun-Soo","Ku, Keunbon","Baek, Seung-Hwa","Kim, Seong-Jun","Kim, Seung Il","Kim, Bum-Tae","Maeng, Jin-Soo","32276051"],"abstract":["Epidemics of Coronavirus Disease 2019 (COVID-19) now have more than 100,000 confirmed cases worldwide. Diagnosis of COVID-19 is currently performed by RT-qPCR methods, but the capacity of RT-qPCR methods is limited by its requirement of high-level facilities and instruments. Here, we developed and evaluated RT-LAMP assays to detect genomic RNA of SARS-CoV-2, the causative virus of COVID-19. RT-LAMP assays in this study can detect as low as 100 copies of SARS-CoV-2 RNA. Cross-reactivity of RT-LAMP assays to other human Coronaviruses was not observed. We also adapted a colorimetric detection method for our RT-LAMP assay so that the tests potentially performed in higher throughput."],"journal":"J Mol Diagn","authors":["Park, Gun-Soo","Ku, Keunbon","Baek, Seung-Hwa","Kim, Seong-Jun","Kim, Seung Il","Kim, Bum-Tae","Maeng, Jin-Soo"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32276051","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.jmoldx.2020.03.006","source":"PubMed","topics":["Diagnosis"],"weight":1,"locations":["Coronaviruses"],"_version_":1664637190087376897,"score":180.05803},{"pmid":32347067,"title":"[Optimization of a fluorescent qPCR detection for RNA of SARS-CoV-2].","text":["[Optimization of a fluorescent qPCR detection for RNA of SARS-CoV-2].","We optimized a fluorescent quantitative polymerase chain reaction (qPCR) assay system for rapid and real time detection of SARS-CoV-2 RNA. The results show that the lowest dilution of RNA samples used for the detection of SARS-CoV-2 RNA could reach 1/10 000 (the initial value is set as 10 ng/muL). Moreover, the cycle threshold (Ct) for samples of clinically diagnosed COVID-19 was lower than 35 or 40. The sensitivity of this method was satisfactory. The results were consistent with those of the COVID-19 detection kit on the market under the same conditions, but the number of cycles required was shortened by about 2. Therefore, the optimized assay developed in this study can be used in screening and early clinical diagnosis. Our work provides a tool to facilitate rapid clinical diagnosis of COVID-19.","Sheng Wu Gong Cheng Xue Bao","Li, Xuelong","Liu, Junhua","Liu, Qianyang","Yu, Lin","Wu, Shanshan","Yin, Xiushan","32347067"],"abstract":["We optimized a fluorescent quantitative polymerase chain reaction (qPCR) assay system for rapid and real time detection of SARS-CoV-2 RNA. The results show that the lowest dilution of RNA samples used for the detection of SARS-CoV-2 RNA could reach 1/10 000 (the initial value is set as 10 ng/muL). Moreover, the cycle threshold (Ct) for samples of clinically diagnosed COVID-19 was lower than 35 or 40. The sensitivity of this method was satisfactory. The results were consistent with those of the COVID-19 detection kit on the market under the same conditions, but the number of cycles required was shortened by about 2. Therefore, the optimized assay developed in this study can be used in screening and early clinical diagnosis. Our work provides a tool to facilitate rapid clinical diagnosis of COVID-19."],"journal":"Sheng Wu Gong Cheng Xue Bao","authors":["Li, Xuelong","Liu, Junhua","Liu, Qianyang","Yu, Lin","Wu, Shanshan","Yin, Xiushan"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32347067","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.13345/j.cjb.200088","keywords":["covid-19","n gene","orf1a gene","sars-cov-2","fluorescence real-time quantitative pcr"],"topics":["Diagnosis"],"weight":1,"_version_":1665441658276151296,"score":177.26688},{"pmid":32325642,"title":"A Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2.","text":["A Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2.","COVID-19 has become a major global public health burden, currently causing a rapidly growing number of infections and significant morbidity and mortality around the world. Early detection with fast and sensitive assays and timely intervention are crucial for interrupting the spread of the COVID-19 virus (SARS-CoV-2). Using a mismatch-tolerant amplification technique, we developed a simple, rapid, sensitive and visual reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay for SARS-CoV-2 detection based on its N gene. The assay has a high specificity and sensitivity, and robust reproducibility, and its results can be monitored using a real-time PCR machine or visualized via colorimetric change from red to yellow. The limit of detection (LOD) of the assay is 118.6 copies of SARS-CoV-2 RNA per 25 muL reaction. The reaction can be completed within 30 min for real-time fluorescence monitoring, or 40 min for visual detection when the template input is more than 200 copies per 25 muL reaction. To evaluate the viability of the assay, a comparison between the RT-LAMP and a commercial RT-qPCR assay was made using 56 clinical samples. The SARS-CoV-2 RT-LAMP assay showed perfect agreement in detection with the RT-qPCR assay. The newly-developed SARS-CoV-2 RT-LAMP assay is a simple and rapid method for COVID-19 surveillance.","Int J Mol Sci","Lu, Renfei","Wu, Xiuming","Wan, Zhenzhou","Li, Yingxue","Jin, Xia","Zhang, Chiyu","32325642"],"abstract":["COVID-19 has become a major global public health burden, currently causing a rapidly growing number of infections and significant morbidity and mortality around the world. Early detection with fast and sensitive assays and timely intervention are crucial for interrupting the spread of the COVID-19 virus (SARS-CoV-2). Using a mismatch-tolerant amplification technique, we developed a simple, rapid, sensitive and visual reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay for SARS-CoV-2 detection based on its N gene. The assay has a high specificity and sensitivity, and robust reproducibility, and its results can be monitored using a real-time PCR machine or visualized via colorimetric change from red to yellow. The limit of detection (LOD) of the assay is 118.6 copies of SARS-CoV-2 RNA per 25 muL reaction. The reaction can be completed within 30 min for real-time fluorescence monitoring, or 40 min for visual detection when the template input is more than 200 copies per 25 muL reaction. To evaluate the viability of the assay, a comparison between the RT-LAMP and a commercial RT-qPCR assay was made using 56 clinical samples. The SARS-CoV-2 RT-LAMP assay showed perfect agreement in detection with the RT-qPCR assay. The newly-developed SARS-CoV-2 RT-LAMP assay is a simple and rapid method for COVID-19 surveillance."],"journal":"Int J Mol Sci","authors":["Lu, Renfei","Wu, Xiuming","Wan, Zhenzhou","Li, Yingxue","Jin, Xia","Zhang, Chiyu"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32325642","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.3390/ijms21082826","keywords":["covid-19","lamp","poct","sars-cov-2","pneumonia"],"topics":["Diagnosis"],"weight":1,"_version_":1665420537598312449,"score":175.41794},{"pmid":32334183,"title":"Rapid point-of-care testing for SARS-CoV-2 in a community screening setting shows low sensitivity.","text":["Rapid point-of-care testing for SARS-CoV-2 in a community screening setting shows low sensitivity.","OBJECTIVE: With the current SARS-CoV2 outbreak, countless tests need to be performed on potential symptomatic individuals, contacts and travellers. The gold standard is a quantitative polymerase chain reaction (qPCR)-based system taking several hours to confirm positivity. For effective public health containment measures, this time span is too long. We therefore evaluated a rapid test in a high-prevalence community setting. STUDY DESIGN: Thirty-nine randomly selected individuals at a COVID-19 screening centre were simultaneously tested via qPCR and a rapid test. Ten previously diagnosed individuals with known SARS-CoV-2 infection were also analysed. METHODS: The evaluated rapid test is an IgG/IgM-based test for SARS-CoV-2 with a time to result of 20 min. Two drops of blood are needed for the test performance. RESULTS: Of 49 individuals, 22 tested positive by repeated qPCR. In contrast, the rapid test detected only eight of those positive correctly (sensitivity: 36.4%). Of the 27 qPCR-negative individuals, 24 were detected correctly (specificity: 88.9%). CONCLUSION: Given the low sensitivity, we recommend not to rely on an antibody-based rapid test for public health measures such as community screenings.","Public Health","Dohla, M","Boesecke, C","Schulte, B","Diegmann, C","Sib, E","Richter, E","Eschbach-Bludau, M","Aldabbagh, S","Marx, B","Eis-Hubinger, A-M","Schmithausen, R M","Streeck, H","32334183"],"abstract":["OBJECTIVE: With the current SARS-CoV2 outbreak, countless tests need to be performed on potential symptomatic individuals, contacts and travellers. The gold standard is a quantitative polymerase chain reaction (qPCR)-based system taking several hours to confirm positivity. For effective public health containment measures, this time span is too long. We therefore evaluated a rapid test in a high-prevalence community setting. STUDY DESIGN: Thirty-nine randomly selected individuals at a COVID-19 screening centre were simultaneously tested via qPCR and a rapid test. Ten previously diagnosed individuals with known SARS-CoV-2 infection were also analysed. METHODS: The evaluated rapid test is an IgG/IgM-based test for SARS-CoV-2 with a time to result of 20 min. Two drops of blood are needed for the test performance. RESULTS: Of 49 individuals, 22 tested positive by repeated qPCR. In contrast, the rapid test detected only eight of those positive correctly (sensitivity: 36.4%). Of the 27 qPCR-negative individuals, 24 were detected correctly (specificity: 88.9%). CONCLUSION: Given the low sensitivity, we recommend not to rely on an antibody-based rapid test for public health measures such as community screenings."],"journal":"Public Health","authors":["Dohla, M","Boesecke, C","Schulte, B","Diegmann, C","Sib, E","Richter, E","Eschbach-Bludau, M","Aldabbagh, S","Marx, B","Eis-Hubinger, A-M","Schmithausen, R M","Streeck, H"],"date":"2020-04-26T11:00:00Z","year":2020,"_id":"32334183","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.puhe.2020.04.009","keywords":["covid-19","coronavirus","outbreak","rapid test","sars-cov-2"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1665071049768697857,"score":164.92705}]}